Kimi Iguchi, See Remarks at Sage Therapeutics, Inc. (SAGE), bought 6,000 shares at $18.00 ($108K) on 2014-07-23, disclosed to the SEC on 2014-07-23.
Open-market purchase of $108k SAGE by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SAGE | SELL | 2018-04-25 | $6.1M | — | Filing → |
| SAGE | SELL | 2017-01-13 | $539K | — | Filing → |
| SAGE | SELL | 2016-11-18 | $207K | — | Filing → |